Live Breaking News & Updates on Nvisa

Stay informed with the latest breaking news from Nvisa on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Nvisa and stay connected to the pulse of your community

Kyowa Hakko's glutathione approved as health ingredient in Brazil

The Brazilian Health Regulatory Agency (ANVISA) has approved Kyowa Hakko’s Setria ingredient, making it the first glutathione authorized for use in dietary supplements and functional foods in the country.

Brazil , United-states , Australia , Brazilian , Karen-todd , Kyowa-hakko , Stratview-research , Kyowa-hakko-united-states-inc , Kyowa-hakko-united-states , Nutraingredients-united-states , Suppliers , Arkets

PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego

PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced that three new state-of-the-art automated sterile fill-finish machines at its San Diego and Melbourne facilities are now fully operational. The innovative machinery from Cytiva can be used to fill various sterile medications into vials and syringes for small-to-mid scale client needs.

Canada , Philadelphia , Pennsylvania , United-states , Ireland , San-diego , California , Japan , Bedford , New-hampshire , Melbourne , Victoria

Dipharma receives GMP certification from Brazilian ANVISA

The Baranzate site (Italy) is the first Dipharma manufacturing facility to receive Anvisa certification...

China , Italy , Milan , Lombardia , Baranzate , Brazil , Italian , Jorge-nogueira , Dipharma-francis , Paola-clerici , Contract-development , Italian-ministry-of-health

Health News Roundup: Brazil approves Pfizer vaccine for children as young as six months; Taiwan eyeing earlier end to COVID quarantine for arrivals and more

Following is a summary of current health news briefs. Brazil approves Pfizer vaccine for children as young as six months Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and four years, the government body said in a statement Friday night.

China , Taiwan , Chongqing , France , Brazil , Chinese , Brazilian , Su-tseng-chang , Pfizer , World-health-organization , Drug-administration

Brazil health regulator says time to ease COVID travel restrictions

People entering the country who have not been vaccinated will still need to show proof of a negative COVID-19 test result, but quarantining will be eliminated immediately. Travelers' health declarations used for tracing COVID cases will no longer be required, with immediate effect, while testing for vaccinated travelers will be suspended from May 1, Anvisa said.

Brazil , United-states , Brazilian , American , Health-ministry , Public-security , South-american , Justice , Ovid , Ealth , Outh-american

Biophytis Received Approval from ANVISA (Brazil) to Give Access to Sarconeos (BIO101) to Hospitalized COVID-19 Patients through an Expanded Access Program

ANVISA (Brazilian Health Authority) approved Biophytis' Expanded Access Program (EAP) for hospitalized patients with severe COVID-19 and mechanically ventilated in Intensive Care UnitSarconeos (BIO101)

Veillet , Rhôalpes , France , Sao-paulo , Sãpaulo , Brazil , United-states , Paris , France-general- , Massachusetts , Cambridge , Cambridgeshire